✦ LIBER ✦

639 POSTER Phase I/II study of PTK/ZK, a novel, oral angiogenesis inhibitor in combination with FOLFIRI as first-line treatment for patients with metastatic colorectal cancer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

297 Preliminary phase I results of the o

✍ T. Trabach; A.L. Thomas; C. Bartel; U. Vanhoefer; W.P. Steward; B. Wiedenmann; M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 165 KB

3061 POSTER Phase I/II study of novel or

✍ M. Tahara; Y. Yamada; A. Ohtsu; K. Shirao; Y. Shimada; Y. Sasaki; W. Yamamoto; T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase I/II study of oxaliplatin with ora

✍ Yamada, Y; Tahara, M; Miya, T; Satoh, T; Shirao, K; Shimada, Y; Ohtsu, A; Sasaki 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

FOLFIRI plus bevacizumab as a first-line

✍ Kochi, Mitsugu; Akiyama, Yuji; Aoki, Tatsuya; Hagiwara, Ken; Takahashi, Takao; H 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 453 KB

‘A phase II study of oral uracil/ftorafu

✍ Bennouna, J; Perrier, H; Paillot, B; Priou, F; Jacob, J H; Hebbar, M; Bordenave, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

Phase 1 study of efatutazone, a novel or

✍ Komatsu, Yoshito; Yoshino, Takayuki; Yamazaki, Kentaro; Yuki, Satoshi; Machida, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 279 KB